There has been a series of confusing studies over estrogen. Many menopausal women went off the drug when increased rates of breast cancer were found. However, recent findings are challenging this conventional wisdom as a “major government study has found that years after using estrogen-only therapy, certain women had a markedly reduced risk of breast cancer and heart attack,” according to The New York Times. The key, says Tara Parker-Pope, reporter for The New York Times, is that these women were only on estrogen, and not progestin. She explains the findings and what this means for women.
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. Will you support The World with a gift today? Donations made between now and Dec. 31 will be matched 1:1. Thanks for investing in our work!